Medication info

Jungwoo Hemobi No. 2 Solution (Sodium Bicarbonate)

Prescription medication
Ingredient · strength
Sodium Bicarbonate›7g / 100mL
Manufacturer / importer
제이더블유생명과학(주)
Appearance
A colorless, transparent liquid contained in a white translucent plastic bottle.
Packaging
10 liters
Approval status
Active

MFDS item code 200601051 · Approved 2006.02.23

Summary

Main use
Alkaline solution for the treatment of chronic kidney failure (hemodialysis)
Who uses it
Adults
Adult dosage
Depending on the patient's condition and the type of artificial kidney used, appropriate acidic solution for hemodialysis should be selected and used after diluting with this solution and purified water.

Ingredients

Manufacturer
제이더블유생명과학(주)

Efficacy & effects

Alkaline solution for the treatment of chronic kidney failure (hemodialysis)

View approved original text

The alkaline solution used for the hemodialysis perfusion fluid in patients with chronic kidney failure helps regulate the internal acid-base balance and assists in removing waste products from the blood, thereby supporting kidney function. This solution plays a critical role in adjusting electrolyte concentrations during dialysis and improving metabolic acidosis, which is used to stabilize the patient's condition.

Dosage and Administration

Adult dosage

Depending on the patient's condition and the type of artificial kidney used, appropriate acidic solution for hemodialysis should be selected and used after diluting with this solution and purified water.

Precautions

This medication is a dialysate used in hemodialysis to help improve metabolic acidosis in patients with chronic kidney failure. Caution is required when using this medication in patients with severe liver impairment or severe diabetes that may impact acetate metabolism. If acetate is not properly metabolized, it may suppress heart function and lead to peripheral vasodilation, which can cause hypotension. Patients taking digitalis preparations should be administered with caution as low serum potassium levels can increase the risk of digitalis toxicity. Patients with high serum calcium and phosphorus levels before dialysis may need to be monitored for metastatic calcification. Be cautious in patients who have inadequate caloric intake, dietary restrictions due to diabetes, or are on hypoglycemic agents as they may experience a risk of hypoglycemia. Hypoglycemic symptoms may occur during or after dialysis, and in such cases, appropriate measures such as glucose injections or sugar intake should be taken. Since serum calcium levels may increase, it is advisable to switch to a low calcium dialysate if hypercalcemia is suspected. Bone-related complications such as osteoporosis, osteomalacia, and fibrous osteitis may occur, necessitating appropriate treatment such as administering active vitamin D3 preparations. If metastatic calcification occurs, phosphate binders should be used to maintain serum phosphorus levels within the normal range. Dialysis disequilibrium syndrome may occur presenting symptoms such as headache, nausea, vomiting, seizures, and altered consciousness, requiring actions to reduce dialysis efficiency. An abrupt decrease in circulating blood volume can lead to symptoms of hypotension or shock, in which case dialysis should be discontinued or the efficiency reduced, and fluid or antihypotensive agents administered. Dialysis dilution water must be safe water that has undergone strict purification processes, and care should also be taken with regards to dialysis membrane integrity and post-operative bleeding tendencies. When compounding, do not mix the electrolyte solutions intended for hemodialysis directly with sodium bicarbonate solutions, and ensure to prepare with the specified diluent accurately. If the dilution concentration is too high or too low, side effects such as headache, palpitations, blood pressure changes, or altered consciousness may occur, so caution is necessary. Before use, the electrolyte concentration, osmotic pressure, and pH of the dialysis solution must be verified to ensure they are appropriate. Remaining sodium bicarbonate solution should not be used, and this medication should not be used for injection or peritoneal perfusion. The dialysate should be used immediately after preparation, and care should be taken as insoluble substances can form if stored at 38°C for more than 2 hours. Pregnant women or women who may become pregnant should only use this medication when the therapeutic benefits outweigh the risks, as its safety has not been established. Safety in pediatric patients has not been established, so special caution is required. For elderly patients, the characteristics of this medication should be carefully considered, and regular monitoring and administration of vitamin D3 preparations are recommended to prevent bone complications if used for extended periods. This medication may cause side effects such as blood sugar fluctuations, weight gain, and increased blood pressure when used with acidic solutions containing glucose, thus regular monitoring of blood sugar, weight, and blood pressure should be practiced.

Side effects and when to seek care immediately

Mild side effects

  • Hypoglycemia
  • hypercalcemia
  • osteoporosis
  • osteomalacia
  • fibrous osteitis
  • metastatic calcification
  • headache
  • nausea
  • vomiting
  • seizures
Show 11 more
  • altered consciousness
  • discomfort
  • fatigue
  • hypotension
  • shock symptoms
  • increased blood pressure
  • weight gain
  • thirst
  • limb weakness
  • general malaise
  • chest discomfort

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent air and moisture ingress. Additionally, it is recommended to keep it away from direct sunlight and store it in a cool room temperature.

Appearance and packaging

Appearance

A colorless, transparent liquid contained in a white translucent plastic bottle.

Package unit

10 liters

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.